Clinical Trials

9 enrolled

Leukemia, Myeloid, Acute

NCT05457010 2024-06-12

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

24 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04021368 2024-02-14

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

112 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05641259 2024-02-02

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

198 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06234904 2024-01-31

Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT06218771 2024-01-23

A Study of TQB3454 Tablets in Patients With Blood Tumors

80 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04284228 2024-01-16

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

22 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

15 enrolled

Leukemia, Myeloid, Acute

NCT04964518 2023-10-25

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

24 enrolled

Leukemia, Myeloid, Acute

NCT05801835 2023-09-21

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

36 enrolled

Leukemia, Myeloid, Acute

NCT06008405 2023-09-06

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

48 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

38 enrolled

Leukemia, Myeloid, Acute

NCT05226468 2023-07-27

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

24 enrolled

Leukemia, Myeloid, Acute

NCT05471323 2023-05-19

Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML

36 enrolled

Leukemia, Myeloid, Acute

NCT04471064 2023-05-18

A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia

60 enrolled

Leukemia, Myeloid, Acute

NCT04265963 2023-04-18

CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia

45 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04272125 2023-04-18

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

40 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT05503355 2023-04-04

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

80 enrolled

Leukemia, Myeloid, Acute

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

120 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Phase 2 Unknown

40 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT04669067 2023-02-17

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT05731219 2023-02-16

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT05722171 2023-02-10

Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Phase 2 Unknown

200 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05445765 2022-07-06

Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05432401 2022-06-27

TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT05426798 2022-06-22

Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes

73 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT04632316 2022-06-21

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

33 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04709458 2022-05-03

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Leukemia, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT03412292 2022-01-19

MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)

30 enrolled

Leukemia, Myeloid, Acute

NCT05017883 2021-11-04

TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia

5 enrolled

Leukemia, Myeloid, Acute

NCT04716114 2021-11-02

ALIVE

Phase 3 Unknown

315 enrolled

Leukemia, Myeloid, Acute

NCT05100303 2021-10-29

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

58 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05061147 2021-10-01

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

100 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04946890 2021-07-01

A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

104 enrolled

Leukemia, Myeloid, Acute

NCT04429191 2021-06-11

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Classical hematologyMyeloidOther hematologic neoplasm

40 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04920500 2021-06-09

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

16 enrolled

Leukemia, Myeloid, Acute

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

20 enrolled

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04806659 2021-03-19

A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia

41 enrolled

Leukemia, Myeloid, Acute

NCT04692948 2021-03-08

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

5 enrolled

Leukemia, Myeloid, Acute

NCT04209712 2020-07-29

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

6 enrolled

Leukemia, Myeloid, Acute

NCT04272957 2020-06-16

A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms

75 enrolled

Leukemia, Myeloid, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT02667093 2020-03-04

Samples From Leukemia Patients and Their Donors to Identify Specific Antigens

Unknown

50 enrolled

Leukemia, Myeloid, Acute

NCT03825146 2020-02-24

AMPCAL

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT03260101 2019-11-26

Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

Unknown

12 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04156256 2019-11-12

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

20 enrolled

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT01211457 2019-07-16

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

65 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT04015024 2019-07-16

A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

Phase 2 Unknown

30 enrolled